New data shows Afghan households have highest welfare use among noncitizens, while Indian households rank lowest, ...

When Crisis Intervention Services received a grant to remodel its Cody facility in 2022, the staff relocated to spaces in the ...

Nearly half of households in the United States headed by a non-citizen benefit from some form of traditional government welfare, according to a newly published analysis. Forty-seven percent of migrant ...

PanARMENIAN.Net - Armenia’s National Assembly Standing Committee on Regional and Eurasian Integration discussed the progress and results of the government program (2021–2026) for 2025 at its March 20 ...

The MarketWatch News Department was not involved in the creation of this content.-- Nadofaragene firadenovec-vncg received an NCCN Category 2A recommendation for patients with pap ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...

In his view, major events such as the Minsk International Book Fair radiate powerful positive energy, focused on preserving ...

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any ...

After a record 2024 in which the corporate PPA market hit a new peak breaking through 3 GW for the first time, 2025 saw something of a "reversion to the mean." ...

NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without CIS who have limited post-BCG options. Radical cystectomy remains ...

Denali Therapeutics (NASDAQ:DNLI) founder and CEO Ryan Watts said 2026 is shaping up to be a pivotal year for the company as ...